Drug intelligence / Profile preview

amoxicillin + minocycline

Development stage
Preclinical
Lead developer
Journey Medical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Amoxicillin + minocycline is a combination of two antibiotics, amoxicillin and minocycline. Amoxicillin is a beta-lactam antibiotic in the penicillin class that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. Minocycline is a tetracycline-class antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing the addition of amino acids to growing peptide chains. Both drugs are used individually for a wide range of bacterial infections; however, their combined use is not standard due to potential antagonistic interactions—minocycline may reduce the effectiveness of amoxicillin when used together[1][6]. This combination has been explored in some research settings (e.g., Helicobacter pylori eradication), but it is not an established or approved fixed-dose product[8]. Each drug retains its own spectrum and mechanism when co-administered.

02

Targets

Bacterial RibosomePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on amoxicillin + minocycline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin + minocycline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call